Inflammatory bowel disease serology in Asia and the West

World Journal of Gastroenterology

Volumn 19, Issue 37, 2013, Pages 6207-6213

  Prideaux, Lani ^a,b   Kamm, Michael A ^a,b,c   De Cruz, Peter ^a,b   van Langenberg, Daniel R ^d   Ng, Siew C ^e   Dotan, Iris ^f  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d BOX HILL HOSPITAL   (Australia)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anti chitobioside antibodies; Anti mannobioside antibodies; Anti Saccharomyces cervisiae antibodies; Antilaminaribioside antibodies; Asia; Atypical perinuclear anti neutrophil cytoplasmic antibodies; Crohn's disease; Ethnic; Serological antibodies; Ulcerative colitis

Indexed keywords

CHITOBIOSE; ENDO 1, 3 BETA GLUCANASE; FUNGUS ANTIBODY; MANNOSE OLIGOSACCHARIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SERODIAGNOSIS; ULCERATIVE COLITIS;

ANTI-CHITOBIOSIDE ANTIBODIES; ANTI-LAMINARIBIOSIDE ANTIBODIES; ANTI-MANNOBIOSIDE ANTIBODIES; ANTI-SACCHAROMYCES CERVISIAE ANTIBODIES; ASIA; ATYPICAL PERINUCLEAR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES; CROHN'S DISEASE; ETHNIC; SEROLOGICAL ANTIBODIES; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES; PREVALENCE; SACCHAROMYCES CEREVISIAE; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84885663038     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i37.6207     Document Type: Article

References (45)

1. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006; 12: 4807-4812 [PMID: 16937461]
2. Prideaux L, De Cruz P, Ng SC, Kamm MA. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 2012; 18: 1340-1355 [PMID: 22069240 DOI: 10.1002/ibd.21903]
3. Dotan N, Altstock RT, Schwarz M, Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus 2006; 15: 442-450 [PMID: 16898180 DOI: 10.1191/0961203306l u2331oa]
4. Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, Lucidarme D, Camus D, Poulain D. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996; 3: 219-226 [PMID: 8991640]
5. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006; 131: 366-378 [PMID: 16890590 DOI: 10.1053/ j.gastro.2006.04.030]
6. Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Lakatos PL. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/ CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 2008; 103: 665-681 [PMID: 18047543 DOI: 10.1111/ j.1572-0241.2007.01652.x]
7. Schwarz M, Spector L, Gargir A, Shtevi A, Gortler M, Altstock RT, Dukler AA, Dotan N. A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody. Glycobiology 2003; 13: 749-754 [PMID: 12851287 DOI: 10.1093/ glycob/cwg091]
8. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-791 [PMID: 9691915 DOI: 10.1136/ gut.42.6.788]
9. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 [PMID: 15168363 DOI: 10.1053/j.gastro.2004.01.063]
10. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54. e42; quiz e30 [PMID: 22001864]
11. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MN, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn' s and colitis epidemiology study. Gastroenterology 2013; 145: 158-165. e2 [PMID: 23583432]
12. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012; 27: 1266-1280 [PMID: 22497584 DOI: 10.1111/j.1440-1746.2012.07150.x]
13. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Targan SR. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto-and microbial antigens. Gastroenterology 2002; 123: 689-699 [PMID: 12198693 DOI: 10.1053/gast.2002.35379]
14. Rieder F, Schleder S, Wolf A, Dirmeier A, Strauch U, Obermeier F, Lopez R, Spector L, Fire E, Yarden J, Rogler G, Dotan N, Klebl F. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflamm Bowel Dis 2010; 16: 263-274 [PMID: 19653286]
15. Hisabe T, Matsui T, Sakurai T, Murakami Y, Tanabe H, Matake H, Yao T, Kamachi S, Iwashita A. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J Gastroenterol 2003; 38: 121-126 [PMID: 12640524 DOI: 10.1007/s005350300020]
16. Kim BG, Kim YS, Kim JS, Jung HC, Song IS. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum 2002; 45: 1062-1069 [PMID: 12195191 DOI: 10.1007/s10350-004-6361-3]
17. Kim BC, Park S, Han J, Kim JH, Kim TI, Kim WH. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. Dig Liver Dis 2007; 39: 610-616 [PMID: 17531556 DOI: 10.1016/j.dld.2007.03.006]
18. Lawrance IC, Murray K, Hall A, Sung JJ, Leong R. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol 2004; 99: 2186-2194 [PMID: 15555001 DOI: 10.1111/j.1572-0241.2004.40486.x]
19. Bernstein CN, El-Gabalawy H, Sargent M, Landers C, Rawsthorne P, Elias B, Targan SR. Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts. Can J Gastroenterol 2011; 25: 269-273 [PMID: 21647462]
20. Kaneko K, Suzuki Y, Shimizu T, Yamashiro Y, Yabuta K, Lifschitz CH. Anti-neutrophil cytoplasmic antibodies in Japanese children with ulcerative colitis. J Paediatr Child Health 1995; 31: 336-338 [PMID: 7576894 DOI: 10.1111/ j.1440-1754.1995.tb00823.x]
21. Lee JH, Cheon JH, Kim ES, Chung MJ, Kang W, Kim DH, Ha YJ, Park JJ, Kim TI, Kim WH. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig Dis Sci 2010; 55: 1406-1412 [PMID: 19507028]
22. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel JF. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998; 93: 1306-1310 [PMID: 9707056 DOI: 10.1111/j.1572-0241.1998.00415.x]
23. Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001; 7: 8-15 [PMID: 11233666 DOI: 10.1097/00054 725-200102000-00002]
24. Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001; 36: 196-201 [PMID: 11252413 DOI: 10.1080/00365520120969]
25. Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol 2001; 96: 2407-2412 [PMID: 11513182 DOI: 10.1111/j.1572-0241.2001.04043.x]
26. Glas J, Török HP, Vilsmaier F, Herbinger KH, Hoelscher M, Folwaczny C. Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their firstdegree relatives: potential clinical value. Digestion 2002; 66: 173-177 [PMID: 12481163 DOI: 10.1159/000066760]
27. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000; 46: 58-63 [PMID: 10601056 DOI: 10.1136/gut.46.1.58]
28. Hadrich I, Vandewalle P, Cheikhrouhou F, Makni F, Krichen MS, Sendid B, Standaert-Vitse A, Ayadi A, Poulain D. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors. Scand J Gastroenterol 2007; 42: 717-725 [PMID: 17505994 DOI: 10.1080/00365520601083625]
29. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107: 532-536 [PMID: 8039629]
30. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, Landers CJ, Targan SR. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103: 456-461 [PMID: 1634063]
31. Lee JC, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995; 108: 428-433 [PMID: 7835584 DOI: 10.1016/001 6-5085(95)90070-5]
32. Folwaczny C, Noehl N, Endres SP, Loeschke K, Fricke H. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33: 523-528 [PMID: 9648993 DOI: 10.1080 /00365529850172106]
33. Bansi DS, Lo S, Chapman RW, Fleming KA. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8: 111-116 [PMID: 8723413 DOI: 10.1097/00042737-199602000-00004]
34. Reumaux D, Delecourt L, Colombel JF, Noël LH, Duthilleul P, Cortot A. Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. Gastroenterology 1992; 103: 1706 [PMID: 1426894]
35. Papo M, Quer JC, Pastor RM, García-Pardo G, Prats E, Mirapeix E, Rodríguez R, Richart C. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 1996; 91: 1512-1515 [PMID: 8759652]
36. Osangthamnont C, Manatsathit S, Pongprasopchai S, Viriyataveekul R, Chaihirunkarn S, Leelakusolvong S, Boonyapisit S. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand. J Gastroenterol Hepatol 2001; 16: 866-871 [PMID: 11555099 DOI: 10.1046/j.1440-1746.2001.02546.x]
37. Yang P, Järnerot G, Danielsson D, Tysk C, Lindberg E. P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995; 36: 887-890 [PMID: 7615278 DOI: 10.1136/ gut.36.6.887]
38. Rieder F, Schleder S, Wolf A, Dirmeier A, Strauch U, Obermeier F, Lopez R, Spector L, Fire E, Yarden J, Rogler G, Dotan N, Klebl F. Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study. Inflamm Bowel Dis 2010; 16: 1367-1375 [PMID: 20024902 DOI: 10.1002/ ibd.21179]
39. Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Seidman EG. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin Gastroenterol Hepatol 2004; 2: 139-146 [PMID: 15017619 DOI: 10.1016/S1542-3565(03)00321-5]
40. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54: 1232-1236 [PMID: 16099791 DOI: 10.1136/gut.2004.060228]
41. Müller S, Styner M, Seibold-Schmid B, Flogerzi B, Mähler M, Konrad A, Seibold F. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis. World J Gastroenterol 2005; 11: 6988-6994 [PMID: 16437604]
42. Rieder F, Lopez R, Franke A, Wolf A, Schleder S, Dirmeier A, Schirbel A, Rosenstiel P, Dotan N, Schreiber S, Rogler G, Klebl F. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis. PLoS One 2011; 6: e18172 [PMID: 21573154 DOI: 10.1371/journal. pone.0018172]
43. Devlin SM, Yang H, Ippoliti A, Taylor KD, Landers CJ, Su X, Abreu MT, Papadakis KA, Vasiliauskas EA, Melmed GY, Fleshner PR, Mei L, Rotter JI, Targan SR. NOD2 variants and antibody response to microbial antigens in Crohn' s disease patients and their unaffected relatives. Gastroenterology 2007; 132: 576-586 [PMID: 17258734 DOI: 10.1053/ j.gastro.2006.11.013]
44. Cruyssen BV, Peeters H, Hoffman IE, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, De Vos M, De Keyser F. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients. Clin Exp Immunol 2005; 140: 354-359 [PMID: 15807862 DOI: 10.1111/j.1365-2249.2005.02759.x]
45. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414-424 [PMID: 14762777 DOI: 10.1053/j.gastro.2003.11.015]